Results 231 to 240 of about 3,564,139 (354)
An Exploratory Review of Potential Adjunct Therapies for the Treatment of Coronavirus Infections. [PDF]
Martin BR, Richardson J.
europepmc +1 more source
Antibody responses to respiratory coronavirus infections of cattle during shipping fever pathogenesis [PDF]
Xiaoqing Lin+4 more
openalex +1 more source
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has known liver tropism. Multiple reports and studies demonstrated liver injury early in the pandemic. This retrospective cross‐sectional comparison evaluates predictors of transaminase elevation during acute SARS‐CoV2 infection, with particular interest in evaluating whether ...
Antonia F. Ovale+6 more
wiley +1 more source
The Immune Responses against Coronavirus Infections: Friend or Foe? [PDF]
Vafaeinezhad A, Atashzar MR, Baharlou R.
europepmc +1 more source
ABSTRACT Introduction Stockholm, Sweden had among the highest excess mortality rates during the first wave of the SARS‐CoV‐2 pandemic. In March 2020, an entire hospital implemented an infection‐free cold site infrastructure and scaled up imperative mainly colorectal cancer surgery, for the Stockholm health care region.
Mattias Soop+4 more
wiley +1 more source
Endolysosome-targeted nanoparticle delivery of antiviral therapy for coronavirus infections. [PDF]
Petcherski A+14 more
europepmc +1 more source
Potential natural candidates in the treatment of coronavirus infections. [PDF]
Alsenani F.
europepmc +1 more source
Entry of coronavirus into primate CNS following peripheral infection
Gary F. Cabirac+7 more
openalex +1 more source
Since the declaration of the COVID‐19 pandemic in Vienna, basal cell carcinoma surgeries decreased by 32.5%, with numbers still not reaching pre‐pandemic levels in 2022. Patients who have undergone surgery since 2020 tend to be older and present with more comorbidities. However, the complexity of surgeries has remained unchanged.
Helena Heinrich+2 more
wiley +1 more source